# Rentschler Biopharma Inc. – FDA Inspection, Jan 17, 2025

Source: https://www.keypedia.com/records/fda_inspections/rentschler-biopharma-inc/fdfa31e1-e0c6-4326-a766-0c0d2116da07
Source feed: FDA_Inspections

> FDA inspection 1259307 of Rentschler Biopharma Inc., January 17, 2025. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1259307
- Company Name: Rentschler Biopharma Inc.
- Inspection Date: 2025-01-17
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New England District Office
- Citation Count: 0

## Related Documents

- [FDA Inspection 1298478 - 2025-12-10](https://www.keypedia.com/records/fda_inspections/rentschler-biopharma-inc/9a33c509-4352-4da8-a638-1145baeb9d2f)
- [FDA Inspection 1202865 - 2023-03-24](https://www.keypedia.com/records/fda_inspections/rentschler-biopharma-inc/677dabb7-4663-4162-b23d-07be45784457)
- FDA Inspection 1116307 - 2019-12-13
- [FDA Inspection 1046134 - 2018-03-26](https://www.keypedia.com/records/fda_inspections/rentschler-biopharma-inc/b20fd2e8-f6c5-4b7f-b897-73d82dc0902f)
- FDA Inspection 961189 - 2016-02-23

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/daniel-l-zheng/5e3d993f-654e-4d40-a2c8-69c5e396499f)
- [Company Rep](https://www.keypedia.com/people/divek-r-jumani/ba9b28e9-d9b3-4c9f-8532-25f037ff7ce4)
- [FDA Associated Person](https://www.keypedia.com/people/sean-r-marcsisin/45c910a9-9019-4419-9af8-b1c9f3b1e976)
- [Issuing Officer](https://www.keypedia.com/people/vivek-jumani/a376992c-ac4c-40b6-ad63-163d726d5ce4)

Company: https://www.keypedia.com/companies/rentschler-biopharma-inc/5ef7256a-aef2-44ce-a792-80c28829c138

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144